Stocks and Investing
Stocks and Investing
Fri, December 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 2, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Blair Abernethy Maintained (SNPS) at Strong Buy with Increased Target to $385 on, Dec 2nd, 2021
Blair Abernethy of Rosenblatt, Maintained "Synopsys, Inc." (SNPS) at Strong Buy with Increased Target from $365 to $385 on, Dec 2nd, 2021.
Blair has made no other calls on SNPS in the last 4 months.
There are 3 other peers that have a rating on SNPS. Out of the 3 peers that are also analyzing SNPS, 0 agree with Blair's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Blair
- John Pitzer of "Credit Suisse" Maintained at Buy with Increased Target to $360 on, Monday, November 29th, 2021
- Vivek Arya of "B of A Securities" Downgraded from Hold to Sell and Held Target at $315 on, Friday, September 17th, 2021
- John McPeake of "Rosenblatt" Maintained at Strong Buy with Increased Target to $349 on, Wednesday, August 25th, 2021
Contributing Sources